51445.1 IP-LS

Résumé

First fully automated point of care solution in personalized medicine for label-free functional cancer drug profiling

Textes supplémentaires

Abstract

A novel drug profiling platform as the first point-of-care solution for patient-specific functional drug testing. Designed for clinical relevance while maintaining scalability, the technology is cost-effective and will be applicable from drug discovery up to guiding clinical therapy decisions.

Participants

Olivier Mauti

Wirtschaftspartner

PreComb Therapeutics AG CHE-371.974.816 Olivier Mauti Garstligweg 8 8634 Hombrechtikon ZH CH

Agathe Koller-Hodac

Kontaktperson

agathe.koller@hsr.ch

OST - Ostschweizer Fachhochschule Institut für Labortechnologie Agathe Koller-Hodac Oberseestrasse 10 8640 Rapperswil SG CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2021-02-28
Date de fin: 2023-06-30
Coûts totaux approuvés: CHF 935080.68
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

T115 Medical technology 100.0%